Search results for "nanotechnology"

showing 10 items of 9818 documents

Crystal structure of chlorido(2-{1-[2-(4-chlorophenyl)hydrazin-1-ylidene-κN]ethyl}pyridine-κN)(η5-pentamethylcyclopentadienyl)rhodium(III) chloride

2015

The title compound, [Rh(η5-C5Me5)Cl(C13H12ClN3)]Cl, is chiral at the metal and crystallizes as a racemate. Upon coordination, the hydrazinyl­idene­pyridine ligand is non-planar, an angle of 54.42 (7)° being observed between the pyridine ring and the aromatic ring of the [2-(4-chloro­phen­yl)hydrazin-1-yl­idene]ethyl group.

crystal structureNanotechnologyCrystal structureRing (chemistry)Medicinal chemistryResearch CommunicationsMetalpenta­methyl­cyclo­penta­dien­yllcsh:Chemistrychemistry.chemical_compoundPyridinepiano-stool geometryGeneral Materials SciencepentamethylcyclopentadienylEthyl grouprhodium(III) complexN—H⋯Cl hydrogen bondHydrogen bondLigandGeneral ChemistryRhodium(III) chlorideN—H...Cl hydrogen bondCondensed Matter Physicschemistrylcsh:QD1-999visual_artvisual_art.visual_art_mediumActa Crystallographica Section E: Crystallographic Communications
researchProduct

Crystal structure of a low-spin poly[di-μ3-cyanido-di-μ2-cyanido-bis(μ2-2-ethylpyrazine)dicopper(I)iron(II)]

2019

In the title metal–organic framework, [Fe(C6H8N2)2{Cu(CN)2}2] n , the low-spin FeII ion lies at an inversion centre and displays an elongated octahedral [FeN6] coordination environment. The axial positions are occupied by two symmetry-related bridging 2-ethylpyrazine ligands, while the equatorial positions are occupied by four N atoms of two pairs of symmetry-related cyanide groups. The CuI centre is coordinated by three cyanide carbon atoms and one N atom of a bridging 2-ethylpyrazine molecule, which form a tetrahedral coordination environment. Two neighbouring Cu atoms have a short Cu...Cu contact [2.4662 (7) Å] and their coordination tetrahedra are connected through a common edge between…

crystal structurePyrazineCyanide02 engineering and technologyCrystal structure010402 general chemistry01 natural sciencesIonmetal–organic frameworkchemistry.chemical_compoundAtomGeneral Materials ScienceBimetallic stripCrystallographyChemistryGeneral Chemistrydicyanocuprate021001 nanoscience & nanotechnologyCondensed Matter Physicsiron(II)0104 chemical sciencescopper(I)CrystallographybimetallicQD901-999Metal-organic frameworkethylpyrazine0210 nano-technologyActa Crystallographica Section E: Crystallographic Communications
researchProduct

Crystal structure and magnetic study of the complex salt [RuCp(PTA)2–μ-CN-1κC:2κN–RuCp(PTA)2][Re(NO)Br4(EtOH)0.5(MeOH)0.5]

2021

A new RuII–ReII complex salt, μ-cyanido-κ2 C:N-bis[(η5-cyclopentadienyl)bis(3,5,7-triazaphosphaadamantane-κP)ruthenium(II)] tetrabromido(ethanol/methanol-κO)nitrosylrhenate(II), [Ru(CN)(C5H5)2(C6H12N3P)4][ReBr4(NO)(CH4O)0.5(C2H6O)0.5] or [RuCp(PTA)2–μ-CN–1κC:2κ2 N-RuCp(PTA)2][Re(NO)Br4(EtOH)0.5(MeOH)0.5] (PTA = 3,5,7-triazaphosphaadamantane) was obtained and characterized by single-crystal X-ray diffraction, elemental analysis and infrared spectroscopy. The title salt was obtained by liquid–liquid diffusion of methanol/DMSO solutions of (NBu4)[Re(NO)Br4(EtOH)] and [(PTA)2CpRu–μ-CN–1κC:2κ2 N-RuCp(PTA)2](CF3SO3). The RuII and ReII independent moieties correspond to a binuclear and mononuclear…

crystal structureSalt (chemistry)Infrared spectroscopychemistry.chemical_element02 engineering and technologyCrystal structure010402 general chemistry01 natural sciencesMedicinal chemistryptachemistry.chemical_compoundGeneral Materials ScienceMagnetic studyQD1-999chemistry.chemical_classificationEthanolChemistryGeneral Chemistry021001 nanoscience & nanotechnologyCondensed Matter Physicsx-ray structure0104 chemical sciencesRutheniumruthenium(ii)ChemistryParameter analysismagnetismrhenium(ii)Methanol0210 nano-technologyActa Crystallographica Section E Crystallographic Communications
researchProduct

Crystal structure of di-μ-isobutyrato-κ(4) O:O'-bis-[cis-di-chlorido-(dimethyl sulfoxide-κS)rhenium(III)].

2015

A binuclear bis­(carboxyl­ato)dirhenium(III) complex is reported. The compound is a representative of a small class of alkyl­carboxyl­ate complexes involving a quadruple metal–metal bonds

crystal structurechemistry.chemical_elementNanotechnologyCrystal structureChlorideIonResearch CommunicationsCrystalchemistry.chemical_compoundquadruple metal–metal bondalkylcarboxylate complexmedicineCluster (physics)General Materials ScienceclusterCrystallographyDimethyl sulfoxideHydrogen bondGeneral ChemistryRheniumCondensed Matter Physicshydrogen bondingrhenium(III)CrystallographychemistryQD901-999alkyl­carboxyl­ate complexmedicine.drugActa crystallographica. Section E, Crystallographic communications
researchProduct

Crystal structure of chlorido(2-{[2-(4-chlorophenyl)hydrazin-1-ylidene-κN1](phenyl)methyl}pyridine-κN)(η5-pentamethylcyclopentadienyl)iridium(III) te…

2015

The title compound, [Ir(η5-C5Me5)Cl(C18H14ClN3)]B(C6H5)4, is chiral at the metal center and crystallizes as a racemate. In the cation, the hydrazinylidenepyridine ligand isN,N-coordinated through theN-pyridyl andN-hydrazinylidene groups forming a five-membered metallacycle. An intramolecular C—H...Cl hydrogen bond is observed. In the crystal, centrosymmetrically-related cations are connected by C—Cl...π interactions, forming a dimeric structure. The crystal packing is further stabilized by weak interionic C—H...π interactions.

crystal structurechemistry.chemical_elementNanotechnologyCrystal structureC—H⋯π inter­actionsintramolecular C—H...Cl hydrogen bondMedicinal chemistryhydrazinyl­idene­pyridine ligandpenta­methyl­cyclo­penta­dien­ylMetallcsh:Chemistrychemistry.chemical_compoundC—H...π interactionsPyridineGeneral Materials SciencepentamethylcyclopentadienylIridiumC—Cl...π interactionsbiologyLigandHydrogen bondintra­molecular C—H⋯Cl hydrogen bondiridium(III) complexGeneral ChemistryMetallacycleCondensed Matter Physicsbiology.organism_classificationData Reportshydrazinylidenepyridine ligandchemistrylcsh:QD1-999visual_artC—Cl⋯π inter­actionsvisual_art.visual_art_mediumTetraActa Crystallographica Section E: Crystallographic Communications
researchProduct

Crystal structure of 5-{3-[2,6-dimethyl- 4-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}- N-(11-hydroxyundecyl)isoxazole-3-carboxamide hemihydrate

2015

The crystal structure and supra­molecular features of 5-{3-[2,6-dimethyl-4-(5-methyl-1,2,4-oxa­diazol-3-yl)phen­oxy]prop­yl}-N-(11-hy­droxy­undec­yl)isoxazole-3-carboxamide hemihydrate, a derivative of anti­viral ‘WIN compounds’, are reported.

crystal structuremedicine.drug_classOxadiazoleCarboxamideNanotechnologyCrystal structureDihedral angleRing (chemistry)Medicinal chemistryResearch Communicationschemistry.chemical_compoundmedicinePeptide bondGeneral Materials ScienceIsoxazoleta116oxa­diazoleCrystallographyChemistryHydrogen bondWIN derivativeisoxazoleGeneral ChemistryCondensed Matter PhysicsantiviralQD901-999anti­viraloxadiazoleActa Crystallographica Section E : Crystallographic Communications
researchProduct

Poly[1-ethyl-3-methylimidazolium [tri-μ-isothiocyanato-manganate(II)]]

2019

The title compound, {(C9H11N2)[Mn(NCS)3]} n , has been obtained as a side product of the salt metathesis reaction of 1-ethyl-3-methylimidazolium bromide, (EMIm)Br, and K2[Mn(NCS)4]. The structure consists of discrete 1-ethyl-3-methylimidazolium cations and an anionic two-dimensional network of manganese(II)-based complex anions, interconnected by thiocyanate ions. Every Mn2+ ion is coordinated by three S atoms of three NCS− ions and three N atoms of further three NCS− ions in a meridional octahedral fashion.

crystal structurethiocyanateThiocyanateManganatechemistry.chemical_elementThio-02 engineering and technologyCrystal structureManganese010402 general chemistry021001 nanoscience & nanotechnology01 natural sciencesMedicinal chemistry0104 chemical scienceschemistry.chemical_compoundnetwork structurechemistryBromideIonic liquidmanganeselcsh:QD901-999Salt metathesis reactionlcsh:Crystallography0210 nano-technologyionic liquidIUCrData
researchProduct

Organic films for the conservation of archaeological artefacts in bronze: evaluation of corrosion protection by surface analytical techniques

2008

cultural heritage bronze nanotechnology
researchProduct

Comparative Surface Morphology, Chemical Composition, and Cytocompatibility of Bio-C Repair, Biodentine, and ProRoot MTA on hDPCs

2020

Biocompatibility is an essential property for any vital pulp material that may interact with the dental pulp tissues. Accordingly, this study aimed to compare the chemical composition and ultrastructural morphology of Biodentine (Septodont, Saint Maur-des-Fosses, France), ProRoot MTA (Dentsply Tulsa Dental Specialties, Johnson City, TN, USA), and Bio-C Repair (Angelus, Londrina, PR, Brazil), as well as their biological effects on human dental pulp cells. Chemical element characterization of the materials was undertaken using scanning electron microscopy and energy dispersive X-ray analysis (SEM-EDX). The cytotoxicity was assessed by analyzing the cell viability (MTT assay), cell morphology …

cytocompatibilityBiocompatibilityvital pulp materialschemistry.chemical_element02 engineering and technologyCalciumCell morphologylcsh:TechnologyArticleFlow cytometry03 medical and health sciences0302 clinical medicinestomatognathic systemdental pulp cellsmedicineGeneral Materials ScienceMTT assayViability assaycalcium silicate materialsCytotoxicitylcsh:Microscopylcsh:QC120-168.85calcium silicate materialmedicine.diagnostic_testlcsh:QH201-278.5Chemistrylcsh:Tdental pulp cell030206 dentistry021001 nanoscience & nanotechnologystomatognathic diseasesendodonticlcsh:TA1-2040Pulp (tooth)lcsh:Descriptive and experimental mechanicslcsh:Electrical engineering. Electronics. Nuclear engineering0210 nano-technologylcsh:Engineering (General). Civil engineering (General)lcsh:TK1-9971Nuclear chemistryMaterials
researchProduct

Iontophoresis: electrorepulsion and electroosmosis.

2000

Over the last 10-15 years, the electrical enhancement of drug delivery across the skin has undergone intense investigation. During this period, considerable amounts of experimental data have been generated, and the successful enhancement of a diverse array of molecules has been achieved. Indeed, the commercial exploitation of the method can be envisaged within the next few years. Despite this progress, however, the mechanistic understanding of iontophoresis remains a challenging scientific question that is yet to be fully resolved. The routes of permeation under the influence of an applied electrical potential, and the molecular interactions of the transporting drug with these pathways, hav…

ddc:615Molecular interactionsOsmosisIontophoresisChemistryPharmaceutical ScienceNanotechnologyIontophoresisAdministration CutaneousDrug Delivery SystemsPharmaceutical technologyElectricitySkin Physiological PhenomenaDrug deliveryDrug Delivery Systems/methodsJournal of controlled release : official journal of the Controlled Release Society
researchProduct